Pharmacophore-based discovery of 2-(phenylamino)aceto-hydrazides as potent eosinophil peroxidase (EPO) inhibitors
There is an increasing interest in developing novel eosinophil peroxidase (EPO) inhibitors, in order to provide new treatment strategies against chronic inflammatory and neurodegenerative diseases caused by eosinophilic disorder. Within this study, a ligand-based pharmacophore model for EPO inhibito...
Saved in:
Main Authors: | Daniela Schuster (Author), Martina Zederbauer (Author), Thierry Langer (Author), Andreas Kubin (Author), Paul G. Furtmüller (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design, synthesis, α-glucosidase inhibition and hypoglycemic activity of 3-aceto(benzo)hydrazide-1,2,4-triazines as potential anti-diabetic agents
by: Mehdi Valipour, et al.
Published: (2024) -
Peroxidasin Inhibition by Phloroglucinol and Other Peroxidase Inhibitors
by: Martina Paumann-Page, et al.
Published: (2023) -
Nasal eosinophilia and eosinophil peroxidase in children and adolescents with rhinitis
by: Yeonu Choi, et al.
Published: (2019) -
Is determining nasal eosinophil count and nasal eosinophil peroxidase concentration clinically useful in children with rhinits?
by: Bong Seok Choi
Published: (2019) -
Pharmacophore-Based Discovery of Viral RNA Conformational Modulators
by: María Martín-Villamil, et al.
Published: (2022)